Corient Capital Partners’s Ambev ABEV Stock Holding History

Corient Capital Partners’s Portfolio ABEV Stock Details ABEV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$32K	Hold	12,770	–	–	﹤0.01%	662
2022 Q2	$32K	Buy	12,770 +563	+5%	+$1.61K	﹤0.01%	676
2022 Q1	$39K	Buy	12,207 +1,231	+11%	+$3.44K	﹤0.01%	735
2021 Q4	$31K	Sell	10,976 -411	-4%	-$1.18K	﹤0.01%	717
2021 Q3	$31K	Buy	11,387 +582	+5%	+$1.84K	﹤0.01%	691
2021 Q2	$37K	Buy	10,805 +201	+2%	+$654	﹤0.01%	674
2021 Q1	$29K	Buy	+10,604	New	+$29.9K	﹤0.01%	618
2020 Q4	–	Sell	-21,398	Closed	-$48K	–	534
2020 Q3	$48K	Buy	+21,398	New	+$53.7K	0.01%	500

Other funds holding ABEV

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

WGI

Westwood Global Investments Boston, Massachusetts $2.68B AUM 76.4% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

SIM

Sprucegrove Investment Management Toronto, Ontario, Canada $625M AUM 21.08% 1-Year Est. Return

Ruffer LLP London, United Kingdom $2.44B AUM 44.75% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Corient Capital Partners's ABEV Position: Q3 2022 in Review

Corient Capital Partners held its Ambev (ABEV) position steady in Q3 2022 at 12,770 shares worth $32K. The position accounts for ﹤0.01% of the portfolio, ranked #662.

Corient Capital Partners first reported a position in ABEV in Q3 2020 and has held it in 8 quarters since. The position peaked at $48K in Q3 2020. 295 funds tracked by Wall St. Rank hold ABEV as of Q3 2022.

Corient Capital Partners held 12,770 shares of Ambev worth $32K as of Q3 2022.
Corient Capital Partners left its Ambev share count unchanged in Q3 2022.
Ambev made up ﹤0.01% of Corient Capital Partners's portfolio in Q3 2022, its #662 holding.
Corient Capital Partners first reported a position in Ambev in Q3 2020 and has held it in 8 quarters since.
Corient Capital Partners's Ambev position peaked at $48K in Q3 2020.
295 funds tracked by Wall St. Rank held Ambev as of Q3 2022.

Based on Corient Capital Partners's 13F filing for Q3 2022, filed 14 Nov 2022.